Eagle Asset Management Inc Takeda Pharmaceutical CO LTD Transaction History

Eagle Asset Management Inc

  • $18.1 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$13.36 - $15.43 $20,694 - $23,901
-1,549 Reduced 4.28%
34,664 $494,000
Q3 2023

Nov 13, 2023
SELL
$15.03 - $16.32 $15,616 - $16,956
-1,039 Reduced 2.79%
36,213 $560,000
Q2 2023

Aug 09, 2023
SELL
$15.57 - $17.11 $21,517 - $23,646
-1,382 Reduced 3.58%
37,252 $585,000
Q1 2023

May 08, 2023
BUY
$15.28 - $16.48 $25,043 - $27,010
1,639 Added 4.43%
38,634 $636,000
Q4 2022

Feb 14, 2023
BUY
$12.42 - $15.62 $459,477 - $577,861
36,995 New
36,995 $577,000

Others Institutions Holding TAK

# of Institutions
320
Shares Held
70.4M
Call Options Held
939K
Put Options Held
233K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email